摘要:
A method of determining the presence or the absence of a glaucoma risk, including the steps of detecting in vitro an allele and/or a genotype of a single nucleotide polymorphism which is located on a 31st base of a base sequence, in a sample from a subject, wherein the base sequence is at least one base sequence selected from the group consisting of base sequences shown in SEQ ID NOs: 203 to 752 or a complementary sequence thereto (step A), and comparing the allele and/or the genotype detected in the step A with at least one of an allele and/or a genotype, containing a high-risk allele, in the base sequences shown in SEQ ID NOs: 203 to 752 (step B). According to the method of the present invention, the level of a progressive risk of glaucoma in a sample donor can be determined by analyzing an allele or a genotype of a single nucleotide polymorphism in the present invention in the sample, so that the sample donor can take a preventive measure of glaucoma, or can receive appropriate treatments, on the basis of this risk.
摘要翻译:一种确定青光眼风险的存在或不存在的方法,包括以下步骤:在位于碱基序列的第31位的单核苷酸多态性的体外检测等位基因和/或基因型, 其中所述碱基序列是选自SEQ ID NO:203至752所示的碱基序列或其互补序列的至少一种碱基序列(步骤A),并比较检测到的等位基因和/或基因型 在SEQ ID NO:203〜752(步骤B)所示的碱基序列中具有含有高风险等位基因的等位基因和/或基因型中的至少一种的步骤A。 根据本发明的方法,可以通过分析样品中本发明的单核苷酸多态性的等位基因或基因型来确定样品供体中青光眼进行性风险的水平,使得样品供体可以 采取预防措施的青光眼,或者可以根据这种风险接受适当的治疗。
摘要:
A method of determining the presence or the absence of a glaucoma risk, including the steps of detecting in vitro an allele and/or a genotype of a single nucleotide polymorphism which is located on a 31st base of a base sequence, in a sample from a subject, wherein the base sequence is at least one base sequence selected from the group consisting of base sequences shown in SEQ ID NOs: 203 to 752 or a complementary sequence thereto (step A), and comparing the allele and/or the genotype detected in the step A with at least one of an allele and/or a genotype, containing a high-risk allele, in the base sequences shown in SEQ ID NOs: 203 to 752 (step B). According to the method of the present invention, the level of a progressive risk of glaucoma in a sample donor can be determined by analyzing an allele or a genotype of a single nucleotide polymorphism in the present invention in the sample, so that the sample donor can take a preventive measure of glaucoma, or can receive appropriate treatments, on the basis of this risk.
摘要翻译:一种确定青光眼风险的存在或不存在的方法,包括以下步骤:在位于碱基序列的第31位的单核苷酸多态性的体外检测等位基因和/或基因型, 其中所述碱基序列是选自SEQ ID NO:203至752所示的碱基序列或其互补序列的至少一种碱基序列(步骤A),并比较检测到的等位基因和/或基因型 在SEQ ID NO:203〜752(步骤B)所示的碱基序列中具有含有高风险等位基因的等位基因和/或基因型中的至少一种的步骤A。 根据本发明的方法,可以通过分析样品中本发明的单核苷酸多态性的等位基因或基因型来确定样品供体中青光眼进行性风险的水平,使得样品供体可以 采取预防措施的青光眼,或者可以根据这种风险接受适当的治疗。
摘要:
A method of determining the presence or the absence of a glaucoma risk, including the steps of detecting in vitro an allele and/or a genotype of a single nucleotide polymorphism which is located on a 31st base of a base sequence, in a sample from a subject, wherein the base sequence is at least one base sequence selected from the group consisting of base sequences shown in SEQ ID NOs: 203 to 752 or a complementary sequence thereto (step A), and comparing the allele and/or the genotype detected in the step A with at least one of an allele and/or a genotype, containing a high-risk allele, in the base sequences shown in SEQ ID NOs: 203 to 752 (step B). According to the method of the present invention, the level of a progressive risk of glaucoma in a sample donor can be determined by analyzing an allele or a genotype of a single nucleotide polymorphism in the present invention in the sample, so that the sample donor can take a preventive measure of glaucoma, or can receive appropriate treatments, on the basis of this risk.
摘要翻译:一种确定青光眼风险的存在或不存在的方法,包括以下步骤:在位于碱基序列的第31位的单核苷酸多态性的体外检测等位基因和/或基因型, 其中所述碱基序列是选自SEQ ID NO:203至752所示的碱基序列或其互补序列的至少一种碱基序列(步骤A),并比较检测到的等位基因和/或基因型 在SEQ ID NO:203〜752(步骤B)所示的碱基序列中具有含有高风险等位基因的等位基因和/或基因型中的至少一种的步骤A。 根据本发明的方法,可以通过分析样品中本发明的单核苷酸多态性的等位基因或基因型来确定样品供体中青光眼进行性风险的水平,使得样品供体可以 采取预防措施的青光眼,或者可以根据这种风险接受适当的治疗。
摘要:
A method of determining the presence or the absence of a glaucoma risk by detecting in vitro an allele and/or a genotype of a single nucleotide polymorphism, comparing the allele and/or the genotype detected with at least one of an allele and/or a genotype with a high-risk allele, wherein the presence of a glaucoma risk is determined in a case where the allele detected is the high-risk allele, or the presence of a glaucoma risk is determined in a case where the genotype detected is a homozygote of the genotype comprising the high-risk allele or a heterozygote when the high-risk allele complies with a dominant genetic model, or the presence of a glaucoma risk is determined in a case where the genotype detected is a homozygote of the genotype comprising the high-risk allele when the high-risk allele complies with a recessive genetic model.
摘要:
A method of determining the presence or the absence of a glaucoma risk, including the steps of detecting in vitro an allele and/or a genotype of a single nucleotide polymorphism which is located on a 31st base of a base sequence, in a sample from a subject, wherein the base sequence is at least one base sequence selected from the group consisting of base sequences shown in SEQ ID NOs: 203 to 514 or a complementary sequence thereto (step A), and comparing the allele and/or the genotype detected in the step A with at least one of an allele and/or a genotype, containing a high-risk allele, in the base sequences shown in SEQ ID NOs: 203 to 514 (step B). According to the method of the present invention, the level of an onset risk of glaucoma in a sample donor can be determined by analyzing an allele or a genotype of a single nucleotide polymorphism in the present invention on the sample, so that the sample donor can take a preventive measure of glaucoma, or can receive appropriate treatments, on the basis of this risk.
摘要翻译:一种确定青光眼风险的存在或不存在的方法,包括以下步骤:在位于碱基序列的第31位的单核苷酸多态性的体外检测等位基因和/或基因型, 其中所述碱基序列是选自SEQ ID NO:203至514所示的碱基序列或其互补序列的至少一种碱基序列(步骤A),并比较检测到的等位基因和/或基因型 具有SEQ ID NO:203〜514(步骤B)所示的碱基序列中的含有高风险等位基因的等位基因和/或基因型中的至少一种的步骤A。 根据本发明的方法,可以通过对样品中的本发明中的单核苷酸多态性的等位基因或基因型进行分析来确定样品供体中的青光眼的发病风险水平,从而样品供体可以 采取预防措施的青光眼,或者可以根据这种风险接受适当的治疗。
摘要:
Provided is a technique for determining a physiological attribute in a mammal, including the onset or progression of human glaucoma, with high accuracy. The results of the determination of genotype date and the results of the determination of cytokine date are consolidated by a consolidated determination unit (114); comparison is made for determining as to which is larger, the number of Case determination procedures or the number of control determination procedures (S330); and it is determined as Case (glaucoma) when the number of Case determination procedures is larger and it is determined as Control (normal person) when the number of Control determination procedures is larger.
摘要:
A battery charger includes a battery attachment section configured to have a rechargeable battery releasably attached thereto. The battery attachment section includes a flat attachment surface having a width corresponding to a width of a bottom surface of a case of the battery to be charged and a length greater than a length of the bottom surface of the case of the battery to be charged; a plurality of locking hooks provided on the attachment surface; a charger terminal configured to contact a terminal of the battery to be charged, the charger terminal including a plurality of plate-shaped contact pieces configured to be inserted into engaging grooves of the battery to be charged; and an attachment projection adjacent to the attachment surface and configured to secure the battery to the charger.
摘要:
According to an aspect of the present invention, there is provided a camera head separated type camera device including: a camera head; a camera control unit; and a cable connecting the camera head and the camera control unit with each other, wherein the camera control unit includes: a control portion which feeds a predetermined DC (Direct Current) voltage to the camera head, and wherein the camera head includes: an LVDS conversion driver portion which transmits an LVDS (Low Voltage Differential Signaling) signal to the camera control unit; a correction control portion which outputs a correction value for the LVDS signal; and an LVDS control portion which controls the LVDS conversion driver portion based on the correction value.
摘要:
A battery charger includes a battery attachment section configured to have a rechargeable battery releasably attached thereto. The battery attachment section includes a flat attachment surface having a width corresponding to a width of a bottom surface of a case of the battery to be charged and a length greater than a length of the bottom surface of the case of the battery to be charged; a plurality of locking hooks provided on the attachment surface; a charger terminal configured to contact a terminal of the battery to be charged, the charger terminal including a plurality of plate-shaped contact pieces configured to be inserted into engaging grooves of the battery to be charged; and an attachment projection adjacent to the attachment surface and configured to secure the battery to the charger.
摘要:
An embodiment of a camera apparatus includes transferring a compressed playback streaming signal output from a recording medium to a map defined in a memory circuit, decoding the transferred playback streaming signal by a decoder, converting the decoded signal to a YUV signal in an image processing unit, transferring the converted signal to the map as a YUV signal, generating a magnified or reduced image from the YUV signal in the image processing unit, and storing the image on the map, overlaying a magnified or reduced image prepared on the map according to a magnified playback request, and outputting the overlaid image for seeking an output position.